<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.22914.018</object-id><label>Table 1.</label><caption><p>ELMO1 is expressed in human TGF&#946;-deficient invasive anorectal SCC.&#160;Human anorectal tumor biopsies from male and female patients, aged 32&#8211;70, were analyzed for phosphorylated (activated) SMAD2 (pSMAD2) and ELMO1 by immunohistochemistry (IHC) (see <xref ref-type="fig" rid="fig7">Figure 7</xref> and <xref ref-type="fig" rid="fig7s1">Figure 7&#8212;figure supplement 1</xref>). Loss of pSMAD2 correlated with increased ELMO1 expression in 5 out of 6 SCC samples. Scoring: (++), strong positive staining; (+), positive staining; (-), negative staining. Abbreviations: SCC: squamous cell carcinoma; AIN3: Anal intraepithelial neoplasia (early stage tumor).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22914.018">http://dx.doi.org/10.7554/eLife.22914.018</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Diagnosis</p></th><th><p>Sex</p></th><th><p>Age</p></th><th><p>pSMAD2</p></th><th><p>ELMO1</p></th><th><p>Pictures</p></th></tr></thead><tbody><tr><td><p>normal anorectal mucosa</p></td><td><p>M</p></td><td><p>58</p></td><td><p>++</p></td><td><p>&#8722;</p></td><td><p><xref ref-type="fig" rid="fig7">Figure 7A</xref></p> </td></tr><tr><td><p>SCC in situ</p> </td><td><p>M</p></td><td><p>47</p></td><td><p>++</p></td><td><p>&#8722;</p></td><td><p><xref ref-type="fig" rid="fig7s1">Figure 7&#8212;figure supplement 1A</xref></p> </td></tr><tr><td><p>SCC in situ + focus of invasion</p></td><td><p>M</p></td><td><p>37</p></td><td><p>++</p></td><td><p>&#8722;</p></td><td valign="bottom"><break/></td></tr><tr><td><p>SCC in situ with microinvasion</p></td><td><p>M</p></td><td><p>69</p></td><td><p>++</p></td><td><p>&#8722;</p></td><td valign="bottom"><break/></td></tr><tr><td><p>SCC in situ + invasive SCC</p></td><td><p>F</p></td><td><p>70</p></td><td><p>++ and &#8722;</p></td><td><p>&#8722;</p></td><td valign="bottom"><break/></td></tr><tr><td><p>AIN3</p></td><td><p>F</p></td><td><p>32</p></td><td><p>++</p></td><td><p>&#8722;</p></td><td><p><xref ref-type="fig" rid="fig7">Figure 7B</xref></p> </td></tr><tr><td><p>AIN3</p></td><td><p>M</p></td><td><p>52</p></td><td><p>++</p></td><td><p>&#8722;</p></td><td valign="bottom"><break/></td></tr><tr><td><p>invasive SCC + AIN3</p></td><td><p>M</p></td><td><p>61</p></td><td><p>++ and &#8722;</p></td><td><p>+</p></td><td valign="bottom"><break/></td></tr><tr><td><p>invasive SCC + AIN3</p></td><td><p>M</p></td><td><p>52</p></td><td><p>++ and &#8722;</p></td><td><p>+</p></td><td valign="bottom"><p><xref ref-type="fig" rid="fig7s1">Figure 7&#8212;figure supplement 1B</xref></p> </td></tr><tr><td><p>invasive SCC grade 2</p></td><td><p>M</p></td><td><p>51</p></td><td><p>++</p></td><td><p>&#8722;</p></td><td valign="bottom"><break/></td></tr><tr><td><p>invasive SCC grade 2</p></td><td><p>M</p></td><td><p>59</p></td><td><p>++</p></td><td><p>&#8722;</p></td><td valign="bottom"><break/></td></tr><tr><td><p>invasive SCC grade 2</p></td><td><p>F</p></td><td><p>51</p></td><td><p>++</p></td><td><p>&#8722;</p></td><td valign="bottom"><break/></td></tr><tr><td><p>invasive SCC grade 3</p></td><td><p>M</p></td><td><p>53</p></td><td><p>++</p></td><td><p>&#8722;</p></td><td valign="bottom"><break/></td></tr><tr><td><p>invasive SCC grade 3</p></td><td><p>F</p></td><td><p>55</p></td><td><p>++ and &#8722;</p></td><td><p>+</p></td><td><p><xref ref-type="fig" rid="fig7">Figure 7C</xref></p> </td></tr><tr><td><p>invasive SCC grade 3</p></td><td><p>F</p></td><td><p>53</p></td><td><p>+ and &#8722;</p></td><td><p>++</p></td><td><p><xref ref-type="fig" rid="fig7">Figure 7D</xref></p> </td></tr><tr><td><p>invasive SCC grade 3</p></td><td><p>M</p></td><td><p>48</p></td><td><p>&#8722;</p></td><td><p>++</p></td><td><p><xref ref-type="fig" rid="fig7">Figure 7E</xref></p> </td></tr></tbody></table></table-wrap>